Literature DB >> 32619523

Diabetes and COVID 19 in South-East Asia.

Shashank R Joshi1, Andrew J M Boulton2.   

Abstract

Entities:  

Year:  2020        PMID： 32619523     DOI： 10.1016/j.diabres.2020.108292

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


× No keyword cloud information.
  2 in total

1.  Impact of diabetes mellitus on COVID-19 clinical symptoms and mortality: Jakarta's COVID-19 epidemiological registry.

Authors:  Dante S Harbuwono; Dwi O T L Handayani; Endang S Wahyuningsih; Novita Supraptowati; Farid Kurniawan; Syahidatul Wafa; Melly Kristanti; Nico I Pantoro; Robert Sinto; Heri Kurniawan; Dicky L Tahapary
Journal:  Prim Care Diabetes       Date:  2021-11-12       Impact factor: 2.459

2.  Evaluation of the Prognosis of COVID-19 Patients According to the Presence of Underlying Diseases and Drug Treatment.

Authors:  Ejin Kim; Yong Chul Kim; Jae Yoon Park; Jiyun Jung; Jung Pyo Lee; Ho Kim
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.